Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511472
Status:
COMPLETED
Last Update Posted:
2015-07-15
First Post:
2007-08-02
Brief Title:
An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin MK-0941-006
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter 2-Part Randomized Double-Blind Placebo-Controlled Multiple-Dose Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of MK-0941 on Postprandial Plasma Glucose Concentrations After Daily Administration MK-0941 Before Each Meal qac in Subjects With Type 2 Diabetes Being Treated With Basal Insulin
Status:
COMPLETED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to assess safety pharmacokinetics PK and pharmacodynamics PD of MK-0941 in Type 2 diabetics being treated with basal insulin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MK-0941-006 | None | None | None |
| 2007_596 | None | None | None |